NMPA Approval

胸腺五肽

Approval Number

国药准字H20084011

Company酒泉大得利制药股份有限公司

Registration Date

June 21, 2024

Drug Information

Generic Name

胸腺五肽

Dosage Form

原料药

Drug Type

化学药品

Registration Date

June 21, 2024

Company Information

Applicant Company

Company Name酒泉大得利制药股份有限公司

Manufacturing Company

Company Name酒泉大得利制药股份有限公司

Company Address

酒泉市高新技术工业园区大得利路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

胸腺五肽 - NMPA 批准文号 | MedPath